Akari Therapeutics (AKTX) Retained Earnings (2011 - 2026)

Akari Therapeutics (AKTX) posted quarterly Retained Earnings of -$279.0 million for Q1 2026, down 11.16% year-on-year from -$314.0 million in Q1 2025, and down 5.46% on a QoQ basis from -$264.6 million in Q4 2025.

Akari Therapeutics (AKTX) Retained Earnings (2011 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has reported Retained Earnings for 16 consecutive years, with -$279.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Retained Earnings fell 11.16% year-over-year to -$279.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$279.0 million (down 11.16% YoY) and the FY2025 annual result came in at -$264.6 million, down 7.0% from the prior year.
  • Retained Earnings fell to -$279.0 million in Q1 2026 per AKTX's latest filing, from -$264.6 million in the prior quarter.
  • Over the last five years, Retained Earnings for AKTX reached as high as -$210.6 million in Q2 2022 and fell as low as -$279.0 million in Q1 2026.
  • A 5-year average of -$242.1 million and a median of -$243.5 million in 2024 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2023 — Retained Earnings decreased 4.6% — and 2026, when it declined 11.16%.
  • Year by year, Retained Earnings stood at -$217.5 million in 2022, then dropped by 4.6% to -$227.5 million in 2023, then slipped by 8.7% to -$247.3 million in 2024, then declined by 7.0% to -$264.6 million in 2025, then slipped by 5.46% to -$279.0 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$279.0 million, -$264.6 million, and -$259.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -527.87 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -27.89 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.91 Bn
4 NuCana 279.75 Bn 279.75 Bn - 115.82 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -622,000.00
10 Akari Therapeutics 86.55 Mn 86.55 Mn - -279.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -279.01 Mn
Dec 31, 2025 -264.55 Mn
Sep 30, 2025 -259.30 Mn
Jun 30, 2025 -252.90 Mn
Mar 31, 2025 -251.00 Mn
Dec 31, 2024 -247.25 Mn
Sep 30, 2024 -243.50 Mn
Jun 30, 2024 -240.60 Mn
Mar 31, 2024 -233.03 Mn
Dec 31, 2023 -227.46 Mn
Jun 30, 2023 -220.50 Mn
Dec 31, 2022 -217.45 Mn
Jun 30, 2022 -210.56 Mn
Dec 31, 2021 -199.71 Mn
Jun 30, 2021 -192.47 Mn
Dec 31, 2020 -648,065.00
Sep 30, 2020 -175.47 Mn
Jun 30, 2020 -176.38 Mn
Mar 31, 2020 -168.94 Mn
Dec 31, 2019 -348,860.00